Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$303M |
| 2 |
General Dynamics
GD
|
+$147M |
| 3 |
Cigna
CI
|
+$95.5M |
| 4 |
CVS Health
CVS
|
+$85.5M |
| 5 |
Marathon Petroleum
MPC
|
+$52.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$234M |
| 2 |
Northrop Grumman
NOC
|
+$218M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$170M |
| 4 |
PX
Praxair Inc
PX
|
+$168M |
| 5 |
COL
Rockwell Collins
COL
|
+$116M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 16.5% |
| 3 | Consumer Discretionary | 11.59% |
| 4 | Communication Services | 10.3% |
| 5 | Industrials | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Repligen
RGEN
$9.45B
| $3.47M | ﹤0.01% |
65,800
+900
| +1% | +$52.8K |
|
1202
Coherent
COHR
$64B
| $3.47M | ﹤0.01% |
106,800
+3,400
| +3% | +$127K |
|
1203
Tandem Diabetes Care
TNDM
$1.61B
| $3.46M | ﹤0.01% |
+91,100
| New | +$3.22M |
|
|
BEAT
1204
DELISTED
BioTelemetry, Inc.
BEAT
| $3.46M | ﹤0.01% |
57,900
+1,300
| +2% | +$78.1K |
|
|
VNE
1205
DELISTED
Veoneer, Inc.
VNE
| $3.45M | ﹤0.01% |
146,400
+2,300
| +2% | +$80.9K |
|
|
ERF
1206
DELISTED
Enerplus Corporation
ERF
| $3.45M | ﹤0.01% |
443,255
+8,900
| +2% | +$86.6K |
|
|
TSE
1207
DELISTED
Trinseo
TSE
| $3.45M | ﹤0.01% |
75,300
-1,000
| -1% | -$54.4K |
|
1208
CNX Resources
CNX
$5.23B
| $3.44M | ﹤0.01% |
301,358
-10,300
| -3% | -$142K |
|
1209
Acadia Realty Trust
AKR
$2.84B
| $3.42M | ﹤0.01% |
144,100
-1,600
| -1% | -$44K |
|
1210
Independent Bank
INDB
$4.05B
| $3.42M | ﹤0.01% |
48,700
+900
| +2% | +$69.8K |
|
1211
International Bancshares
IBOC
$4.52B
| $3.42M | ﹤0.01% |
99,400
+1,700
| +2% | +$65.4K |
|
|
XHR
1212
Xenia Hotels & Resorts
XHR
$1.73B
| $3.4M | ﹤0.01% |
197,880
+12,000
| +6% | +$244K |
|
|
TMHC
1213
DELISTED
Taylor Morrison
TMHC
| $3.4M | ﹤0.01% |
214,000
+20,000
| +10% | +$327K |
|
1214
AutoNation
AN
$6.9B
| $3.4M | ﹤0.01% |
95,300
-8,700
| -8% | -$329K |
|
1215
TriNet
TNET
$3.22B
| $3.4M | ﹤0.01% |
81,100
+1,800
| +2% | +$82.8K |
|
|
ARNA
1216
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $3.4M | ﹤0.01% |
87,230
+1,400
| +2% | +$55K |
|
1217
The Ensign Group
ENSG
$10.6B
| $3.39M | ﹤0.01% |
93,538
+1,818
| +2% | +$70.8K |
|
1218
Edgewell Personal Care
EPC
$1.32B
| $3.39M | ﹤0.01% |
90,800
+1,500
| +2% | +$65.4K |
|
|
CHK
1219
DELISTED
Chesapeake Energy Corporation
CHK
| $3.39M | ﹤0.01% |
8,066
+158
| +2% | +$109K |
|
|
SGI
1220
Somnigroup International
SGI
$13.5B
| $3.39M | ﹤0.01% |
327,200
+7,600
| +2% | +$91.1K |
|
1221
Frontdoor
FTDR
$5.83B
| $3.38M | ﹤0.01% |
+126,903
| New | +$3.76M |
|
1222
Conduent
CNDT
$241M
| $3.37M | ﹤0.01% |
317,354
+6,300
| +2% | +$98.1K |
|
1223
B&G Foods
BGS
$299M
| $3.37M | ﹤0.01% |
116,600
+800
| +0.7% | +$22.9K |
|
1224
Paylocity
PCTY
$8.1B
| $3.37M | ﹤0.01% |
55,950
+1,000
| +2% | +$64.1K |
|
1225
NETSCOUT
NTCT
$2.89B
| $3.37M | ﹤0.01% |
142,428
+2,400
| +2% | +$60.5K |
|
Similar funds
Swiss National Bank's Q4 2018 Portfolio in Review
As of Q4 2018, Swiss National Bank held 2,591 positions worth $78B, down 13% from $89.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Swiss National Bank's Q4 2018 filing shows 87 new, 1,610 increased, 323 reduced and 55 closed positions. Its largest new stake was Linde: 1,915,836 shares worth $299M. The largest sale was Aetna Inc, an estimated $234M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q4 2018 buy was Linde: 1,915,836 shares worth $299M.
- Swiss National Bank added most to Cigna in Q4 2018, an estimated $95.5M increase.
- Swiss National Bank's biggest Q4 2018 reduction was Dell, cutting an estimated $52.3M.
- Swiss National Bank fully exited Aetna Inc in Q4 2018, selling an estimated $234M.
- Swiss National Bank's ten largest holdings make up 18% of its $78B portfolio in Q4 2018.
- Swiss National Bank opened 87 new positions and closed 55 in Q4 2018.
- Swiss National Bank's portfolio value fell 13% quarter-over-quarter to $78B.
Based on Swiss National Bank's 13F filing for Q4 2018, filed 13 Feb 2019.